IRIS Accounts Production v24.3.2.46 10031406 Board of Directors 1.6.23 31.5.24 31.5.24 a microbiological testing laboratory specialising in disinfectant and preservative efficacy testing, and microbiological quality testing of cosmetics and personal care products. false true false false false true false Ordinary 0.10000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh100314062023-05-31100314062024-05-31100314062023-06-012024-05-31100314062022-05-31100314062022-06-012023-05-31100314062023-05-3110031406ns15:EnglandWales2023-06-012024-05-3110031406ns14:PoundSterling2023-06-012024-05-3110031406ns10:Director12023-06-012024-05-3110031406ns10:PrivateLimitedCompanyLtd2023-06-012024-05-3110031406ns10:SmallEntities2023-06-012024-05-3110031406ns10:Audited2023-06-012024-05-3110031406ns10:SmallCompaniesRegimeForDirectorsReport2023-06-012024-05-3110031406ns10:SmallCompaniesRegimeForAccounts2023-06-012024-05-3110031406ns10:FullAccounts2023-06-012024-05-3110031406ns10:OrdinaryShareClass12023-06-012024-05-3110031406ns10:Director52023-06-012024-05-3110031406ns10:Director62023-06-012024-05-3110031406ns10:Director72023-06-012024-05-3110031406ns10:Director82023-06-012024-05-3110031406ns10:CompanySecretary12023-06-012024-05-3110031406ns10:RegisteredOffice2023-06-012024-05-3110031406ns10:Director22023-06-012024-05-3110031406ns10:Director32023-06-012024-05-3110031406ns10:Director42023-06-012024-05-3110031406ns5:RetainedEarningsAccumulatedLosses2023-05-3110031406ns5:RetainedEarningsAccumulatedLosses2022-05-3110031406ns5:RetainedEarningsAccumulatedLosses2024-05-3110031406ns5:RetainedEarningsAccumulatedLosses2023-05-3110031406ns5:CurrentFinancialInstruments2024-05-3110031406ns5:CurrentFinancialInstruments2023-05-3110031406ns5:ShareCapital2024-05-3110031406ns5:ShareCapital2023-05-3110031406ns5:PlantMachinery2023-06-012024-05-3110031406ns5:PlantMachinery2023-05-3110031406ns5:PlantMachinery2024-05-3110031406ns5:PlantMachinery2023-05-3110031406ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-05-3110031406ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-05-3110031406ns5:DeferredTaxation2023-05-3110031406ns5:DeferredTaxation2023-06-012024-05-3110031406ns5:DeferredTaxation2024-05-3110031406ns10:OrdinaryShareClass12024-05-3110031406ns5:RetainedEarningsAccumulatedLosses2023-06-012024-05-311003140612023-06-012024-05-31
REGISTERED NUMBER: 10031406 (England and Wales)



















REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MAY 2024

FOR

ABBOTT ANALYTICAL LIMITED

ABBOTT ANALYTICAL LIMITED (REGISTERED NUMBER: 10031406)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024




Page

Company Information 1

Report of the Directors 2

Independent Auditor's Report 4

Statement of Income and Retained Earnings 8

Balance Sheet 9

Notes to the Financial Statements 10


ABBOTT ANALYTICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MAY 2024







DIRECTORS: S Donnachie
A M Rocklin
M L Mittino
W J Waelke
D E Jones





SECRETARY: Corporation Service Company (UK) Limited





REGISTERED OFFICE: C/O Corporation Sevice Company (UK) Ltd
5 Churchill Place
10th Floor
London
E14 5HU





REGISTERED NUMBER: 10031406 (England and Wales)





AUDITOR: BDO LLP
Statutory Auditor
Citypoint
65 Haymarket Terrace
Edinburgh, UK
EH12 5HD

ABBOTT ANALYTICAL LIMITED (REGISTERED NUMBER: 10031406)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 MAY 2024

The directors present their report with the financial statements of the company for the year ended 31 May 2024.

EVENTS SINCE THE END OF THE YEAR
As noted in note 10 below, subsequent to the year end on 16th January 2025, the decision was taken to cease the company's business and, in due course, apply to have the company struck-off at Companies House.

DIRECTORS
S Donnachie has held office during the whole of the period from 1 June 2023 to the date of this report.

Other changes in directors holding office are as follows:

J Adent - resigned 24 October 2023
Dr J W Lilly - resigned 17 July 2023
S J Quinlan - resigned 17 July 2023
A M Rocklin - appointed 17 July 2023
M L Mittino - appointed 17 July 2023
W J Waelke - appointed 17 July 2023
D E Jones - appointed 17 July 2023

The directors who were in office at the date the financial statements were approved are detailed on page 1.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the
company will continue in business. As stated in Note 2, the directors do not consider the Company to be a
going concern and have prepared the finanical statements on a basis other than going concern.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITOR
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditor is unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditor is aware of that information.

AUDITOR
The auditor, BDO LLP, will be proposed for re-appointment at the forthcoming Annual General Meeting.


ABBOTT ANALYTICAL LIMITED (REGISTERED NUMBER: 10031406)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 MAY 2024

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





S Donnachie - Director


13 March 2025

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF
ABBOTT ANALYTICAL LIMITED

Opinion on the financial statements

In our opinion the financial statements:

- give a true and fair view of the state of the company's affairs as at 31 May 2024 and of its loss for the
year then ended;

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting
Practice; and

- have been prepared in accordance with the requirements of the Companies Act 2006.

We have audited the financial statements of Abbott Analytical Limited ("the company") for the year ended 31 May 2024 which comprise the Statement of Income and Retained Earnings, the Balance Sheet and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor's responsibilities for the audit of the financial statements section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Independence
We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements.

Emphasis of matter - financial statements prepared on a basis other than going concern
We draw attention to Note 2 to the financial statementswhich explains that the Directors intend to cease operations of the Company, and initiate steps to liquidate the Company.Therefore, the directors do not consider it appropriate to adopt the going concern basis of accounting in preparing the financial statements. Accordingly, the financial statements have been prepared on a basis other than going concern as described in Note 2. Our opinion is not modified in respect of this matter.

Other information
The directors are responsible for the other information. The other information comprises the information included in the Report of the Directors and Financial Statements for the Year Ended 31 May 2024, other than the financial statements and our auditor's report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.











INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF
ABBOTT ANALYTICAL LIMITED

Other Companies Act 2006 reporting
In our opinion, based on the work undertaken in the course of the audit:

- the information given in the Report of the Directors for the financial year for which the
financial statements are prepared is consistent with the financial statements; and

- the Report of the Directors has been prepared in accordance with applicable legal
requirements.

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Report of the Directors.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

- adequate accounting records have not been kept, or returns adequate for our audit have not been
received from branches not visited by us; or

- the financial statements are not in agreement with the accounting records and returns; or

- certain disclosures of directors' remuneration specified by law are not made; or

- we have not received all the information and explanations we require for our audit.

- the Directors were not entitled to take advantage of the small companies' exemptions in preparing
the Report of the Directors and from the requirement to prepare a Strategic Report.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so. As stated in note 10, the Directors do not consider the company to be a going concern and have prepared the finanial statements on a basis other than going concern.

Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Extent to which the audit was capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:









INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF
ABBOTT ANALYTICAL LIMITED

Non-compliance with laws and regulations
Based on:
- Our understanding of the company and the industry in which it operates;
- Discussion with management and those charged with governance;
- Obtaining and understanding of the company's policies and procedures regarding compliance with
laws and regulations; and
we considered the significant laws and regulations to be the applicable accounting framework, UK tax legislation, Companies Act 2006.

The company is also subject to laws and regulations where the consequence of non-compliance could have a material effect on the amount or disclosures in the financial statements, for example through the imposition of fines or litigations. We identified such laws and regulations to be Companies Act 2006, Corporate and VAT legislations, Employment Taxes, Health and Safety and the Bribery Act 2020.

Our procedures in respect of the above included:
- Review of minutes of meeting of those charged with governance for any instances of non-compliance
with laws and regulations;
- Review of financial statement disclosures and agreeing to supporting documentation; and
- Review of legal expenditure accounts to understand the nature of expenditure incurred.

Fraud
We assessed the susceptibility of the financial statements to material misstatement, including fraud. Our risk assessment procedures included:
- Enquiry with management and those charged with governance regarding any known or suspected
instances of fraud;
- Obtaining an understanding of the company's policies and procedures relating to:
- Detecting and responding to the risks of fraud; and
- Internal controls established to mitigate risks related to fraud.
- Review of minutes of meeting of those charged with governance for any known or suspected
instances of fraud;
- Discussion amongst the engagement team as to how and where fraud might occur in the financial
statements; and
- Performing analytical procedures to identify any unusual or unexpected relationships that may indicate
risks of material misstatement due to fraud; and
- Considering remuneration incentive schemes and performance targets and the related financial
statement areas impacted by these.

Based on our risk assessment, we considered the areas most susceptible to fraud to be management override of controls and revenue recognition.

Our procedures in respect of the above included:
- Testing a sample of journal entries throughout the year, which met a defined risk criteria, by agreeing to
supporting documentation;
- Carrying out detailed testing, on sample basis, of revenue transactions which occurred around the year
end agreeing to lab completion reports ensuring that revenue is recognised in the correct period.

We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members who were all deemed to have appropriate competence and capabilities and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

Our audit procedures were designed to respond to risks of material misstatement in the financial statements, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery, misrepresentations or through collusion. There are inherent limitations in the audit procedures performed and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we are to become aware of it.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditor's Report.




INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF
ABBOTT ANALYTICAL LIMITED

Use of our report
This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Alastair Rae (Senior Statutory Auditor)
for and on behalf of BDO LLP
Statutory Auditor
Edinburgh, UK

18 March 2025

ABBOTT ANALYTICAL LIMITED (REGISTERED NUMBER: 10031406)

STATEMENT OF INCOME AND RETAINED EARNINGS
FOR THE YEAR ENDED 31 MAY 2024

2024 2023
£    £   

TURNOVER 131,252 228,748

Cost of sales 141,163 135,354
GROSS (LOSS)/PROFIT (9,911 ) 93,394

Administrative expenses 43,768 50,384
(53,679 ) 43,010

Other operating income 9,375 -
OPERATING (LOSS)/PROFIT (44,304 ) 43,010


Interest payable and similar expenses 404 -
(LOSS)/PROFIT BEFORE TAXATION (44,708 ) 43,010

Tax on (loss)/profit 420 6,558
(LOSS)/PROFIT FOR THE FINANCIAL
YEAR

(45,128

)

36,452

Retained earnings at beginning of year 267,451 230,999

RETAINED EARNINGS AT END OF
YEAR

222,323

267,451

ABBOTT ANALYTICAL LIMITED (REGISTERED NUMBER: 10031406)

BALANCE SHEET
31 MAY 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 3,917 6,850

CURRENT ASSETS
Debtors 5 21,189 22,569
Cash at bank 224,901 286,940
246,090 309,509
CREDITORS
Amounts falling due within one year 6 25,701 45,200
NET CURRENT ASSETS 220,389 264,309
TOTAL ASSETS LESS CURRENT
LIABILITIES

224,306

271,159

PROVISIONS FOR LIABILITIES 7 983 2,708
NET ASSETS 223,323 268,451

CAPITAL AND RESERVES
Called up share capital 8 1,000 1,000
Retained earnings 9 222,323 267,451
SHAREHOLDERS' FUNDS 223,323 268,451

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 13 March 2025 and were signed on its behalf by:





S Donnachie - Director


ABBOTT ANALYTICAL LIMITED (REGISTERED NUMBER: 10031406)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024

1. STATUTORY INFORMATION

Abbott Analytical Limited is a private company, limited by shares, registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page (page 1). The company operates as a microbiological testing laboratory.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements have been prepared in pounds sterling which is the functional currency of the company, rounded to the nearest pound.

The significant accounting policies applied in the presentation of these financial statements are set out below.

Basis other than going concern
As noted in note 10 below, subsequent to the year end, the Directors intend to cease operations of the Company, and initiate steps to liquidate the Company. Therefore, the directors do not consider it to be appropriate to adopt the going concern basis of accounting in preparing the financial statements. Accordingly, the financial statements have been prepared on a basis other than going concern. No adjustments were required to the financial statements as a result of preparing them on a basis other than going concern.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover
Turnover is measured at the fair value of the consideration received or receivable net of VAT and trade discounts. The policies adopted for the recognition of turnover are as follows:

Rendering of services
The company provides analysis and testing services and recognises revenue from such services when the test/analysis is complete and reported to the customer.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance and 20% on reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Statement of Income and Retained earnings.


ABBOTT ANALYTICAL LIMITED (REGISTERED NUMBER: 10031406)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2024

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Foreign currency transactions are initially recognised by applying to the foreign currency amount the spot exchange rate between the functional currency and the foreign currency at the date of the transaction.

Monetary assets and liabilities denominated in a foreign currency at the balance sheet date are translated using the closing rate.

Pension costs and other post-retirement benefits
The company operates a defined contribution scheme. The assets of the scheme are held separately from those of the company in independently administered funds. Contributions payable to the scheme are charged to the Statement of Income and Retained Earnings in the period to which they relate.

Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice if not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Creditors
Short term creditors are measured at transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

ABBOTT ANALYTICAL LIMITED (REGISTERED NUMBER: 10031406)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2024

2. ACCOUNTING POLICIES - continued

Impairment
Assets are reviewed for any indication that the asset may be impaired at each Balance Sheet date. If such indication exists, the recoverable amount of the asset, or the asset's cash generating unit, is estimated and compared to the carrying amount. Where the carrying amount exceeds its recoverable amount, an impairment loss is recognised in the Statement of Income and Retained Earnings.

Operating leases
Rentals paid under operating leases are charged to the Statement of Income and Retained Earnings on a straight line basis over the lease term.

Employee benefits
When employees have rendered service to the company, short term benefits (including holiday pay) to which employees are entitled are recognised at the undiscounted amount expected to be paid in exchange for that service.

Finance costs
Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Critical accounting judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported as assets, liabilities, revenues and expenses for the period. The key sources of estimation uncertainty are as follows:

Depreciation of tangible fixed assets:
Tangible fixed assets are depreciated over their useful lives taking into account residual values, where appropriate. The expected lives of assets and their residual values are assessed regularly and may vary depending on a number of factors including technological innovation, product life cycles, future market conditions and maintenance programmes.

Impairment of assets:
Tangible fixed assets, stock and debtors are all reviewed for evidence of impairment.

In connection with fixed assets, factors taken into consideration include the economic viability, the expected future financial performance of the asset and, where appropriate, the viability and expected future performance of related cash generating units.

Trade debtors are reviewed for evidence of impairment. Factors considered include ageing, past recovery rates, customer creditworthiness, and the stage and expected outcome of any recovery proceedings.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2023 - 4 ) .

The directors are remunerated by other group companies and they are not therefore included in the average number of employees above.

ABBOTT ANALYTICAL LIMITED (REGISTERED NUMBER: 10031406)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 June 2023 23,450
Additions 1,292
At 31 May 2024 24,742
DEPRECIATION
At 1 June 2023 16,600
Charge for year 4,225
At 31 May 2024 20,825
NET BOOK VALUE
At 31 May 2024 3,917
At 31 May 2023 6,850

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 13,222 15,476
Amounts owed by group undertakings 3,877 408
Other debtors 4,090 6,685
21,189 22,569

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 3,880 5,048
Amounts owed to group undertakings 2,320 2,958
Taxation and social security 3,424 20,875
Other creditors 16,077 16,319
25,701 45,200

7. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax - accelerated capital
allowances

983

2,708

Deferred
tax
£   
Balance at 1 June 2023 2,708
Credit to Statement of Income and Retained Earnings during year (1,725 )
Balance at 31 May 2024 983

ABBOTT ANALYTICAL LIMITED (REGISTERED NUMBER: 10031406)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2024

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
10,000 Ordinary £0.10 1,000 1,000

9. RESERVES
Retained
earnings
£   

At 1 June 2023 267,451
Deficit for the year (45,128 )
At 31 May 2024 222,323

Retained earnings represent cumulative profits and losses net of dividends and other adjustments.

10. POST BALANCE SHEET EVENTS

On 16 January 2025 it was decided to wind-down and close the company's business with cessation expected in March 2025. All employees will unfortunately be made redundant.

The decision to close the business was made post year in an effort to streamline group operations, rather than reflecting the company’s inability to continue to trade as a going concern at 31 May 2024. The company is expected to recover all material assets and meet all its liabilities on or subsequent to cessation, including related redundancy liabilities (unprovided at 31 May 2024).

No adjustment has been made to the assets and liabilities at 31 May 2024 in respect of the (now) expected closure.

11. ULTIMATE CONTROLLING PARTY

The company's immediate parent company is Neogen Europe Limited, incorporated and based in the United Kingdom. Its ultimate parent company and the parent of the smallest group which draws up consolidated financial statements is Neogen Corporation, a publicly owned company based in the United States of America whose shares are traded on the NASDAQ Stock Market. Copies of the group financial statements for Neogen Corporation are available from Neogen Corporation, 620 Lesher Place, Lansing, MI 48912, USA.